Inverse determination of the fatigue Strain Energy Density control radius for conventionally and additively manufactured rounded V-notches

The Strain Energy Density (SED) fatigue criterion is based on a material control radius. The value of this length is therefore required for an accurate assessment of the fatigue strength of any, especially severely, notched components. The singularity-based control radius is initially obtained by considering the hypothetical perfectly sharp V-notched specimen. The effect of the notch radius on the inverse search is then investigated with numerical simulations, and a new analytical procedure is introduced for the determination of the (actual) control radius. This procedure is applied to the experimental data of three metal alloys with different load ratios and manufacturing conditions

Modelling and Parameter Identification of Ex-Situ Biological Biogas Upgrading

In this paper, a model of ex-situ biological biogas upgrading process is first developed. Then, parameter sensitivity analysis is performed, in order to determine the most relevant parameters for subsequent parameter identification, based on a linear fractional transformation (LFT) reformulation of the model. Biogas composition and volumetric production have been well predicted by the calibrated model, allowing its adoption as a designing tool for start-up operation of experimental pilot-scale activity

Fatigue investigation at high load ratio R of a quenched and tempered chromium molybdenum steel

Abstract The fatigue behavior at high number of cycles in elastic-plastic field of quenched and tempered carbon chromium steel was experimentally investigated for high performance reciprocating compressors application. Fatigue tests on un-notched specimens were performed both under load and strain controls, by imposing different levels of stress/strain and for each of them different values of stress ratios R, especially high values. Stress and strain trends have been monitored, during the fatigue life, and either ratcheting or relaxation, respectively, was evident. The stress control tests have resulted into fatigue fractures only for low values of R with significant ratcheting and an increasing rate during the final part of the test, thus the fracture could be considered as a synergy between fatigue damage and plastic failure. On the contrary, the ratcheting stabilized for high values of R and the tests were finalized without any fracture. Within an intermediate region, for medium/high values of R, a minor ratcheting and the fracture transition have been found. Similarly, for the tests under strain control, low values of R showed fatigue fractures despite a considerable relaxation, conversely for high values of R, the relaxation was limited without any fracture. After reporting the tests on the Haigh plane, the Smith-Watson-Topper equation (SWT) provided the best prediction of the fatigue strength, at least until the intersection with the ultimate stress line, both under stress and strain control loadings. The cyclic behavior of the material was then investigated through several static and cyclic tests on plain specimens. A kinematic hardening Chaboche model, with three parameter couples, was proposed and the values of these parameters derived and discussed. Finally, other tests have been conducted on notched specimens with C geometry and blunt radius, again at high R values. FE analysis allowed the prediction of the stress evolution during the loading cycling, implementing the Chaboche model, and observing a combined effect of ratcheting and relaxation at the notch tip. The stabilized stresses were finally reported on the Haigh diagram and the results were found in agreement with the plain specimen fatigue line

The airways' mechanical stress in lung disease: Implications for COPD pathophysiology and treatment evaluation

The airway epithelium stretches and relaxes during the normal respiratory cycle, and hyperventilation exaggerates this effect, resulting in changes in lung physiology. In fact, stretching of the airways influences lung function and the secretion of airway mediators, which in turn may cause a potentially injurious inflammatory response. This aim of the present narrative review was to illustrate the current evidence on the importance of mechanical stress in the pathophysiology of lung diseases with a particular focus on chronic obstructive pulmonary disease (COPD) and to discuss how this may influence pharmacological treatment strategies. Overall, treatment selection should be tailored to counterpart the effects of mechanical stress, which influences inflammation both in asthma and COPD. The most suitable treatment approach between a long-acting \u3b22-agonists/long-acting antimuscarinic-agonist (LABA/LAMA) alone or with the addition of inhaled corticosteroids should be determined based on the underlying mechanism of inflammation. Noteworthy, the anti-inflammatory effects of the glycopyrronium/indacaterol combination on hyperinflation and mucociliary clearance may decrease the rate of COPD exacerbations, and it may synergistically improve bronchodilation with a double action on both the cyclic adenosine monophosphate (cAMP) and the acetylcholine pathways

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD

It has been shown that patients with chronic obstructive pulmonary disease (COPD) develop dynamic hyperinflation (DH), which contributes to dyspnoea and exercise intolerance. Formoterol, salmeterol and oxitropium have been recommended for maintenance therapy in COPD patients, but their effect on DH has only been assessed for salmeterol. The aim of the present study was to compare the acute effect of four inhaled bronchodilators (salbutamol, formoterol, salmeterol and oxitropium) and placebo on forced expiratory volume in one second, inspiratory capacity, forced vital capacity and dyspnoea in COPD patients. A cross-over, randomised, double-blind, placebo-controlled study was carried out on 20 COPD patients. Patients underwent pulmonary function testing and dyspnoea evaluation, in basal condition and 5, 15, 30, 60 and 120 min after bronchodilator or placebo administration. The results indicate that in chronic obstructive pulmonary disease patients with decreased baseline inspiratory capacity, there was a much greater increase of inspiratory capacity after bronchodilator administration, which correlated closely with the improvement of dyspnoea sensation at rest. For all bronchodilators used, inspiratory capacity reversibility should be tested at 30 min following the bronchodilator. On average, formoterol elicited the greatest increase in inspiratory capacity than the other bronchodilators used, though the difference was significant only with salmeterol and oxitropium. The potential advantage of formoterol needs to be tested in a larger patient population

A fatigue multi-site cracks model using coalescence, short and long crack growth laws, for anodized aluminum alloys

It has been shown that decrease of the fatigue life of aluminium alloys treated with anodization can be explained by the degradation of surface condition due to pickling. In order to predict fatigue life of anodized aluminium alloys, a multi-site crack growth model is developed by considering the pickling pits sites as initial flaws from which fatigue cracks develop. A map of the pickled surface is built from topography measurement with a contact profilometer. Then the pits are detected and their sizes are defined (depth, length and width). At the beginning of the calculation, a short crack growth law is used for crack having depths less than grain size. Then Paris long crack growth law is used. The coalescence of cracks is considered when their lengths increased by its crack tip plastic zone are large enough to interact with other neighbouring short cracks. The fatigue life is calculated for Kmax achieving 70 % KIC

The evidence on tiotropium bromide in asthma: from the rationale to the bedside

Severe and poorly controlled asthma still accounts for a great portion of the patients affected. Disease control and future risk management have been identified by international guidelines as the main goals in patients with asthma. The need for new treatment approaches has led to reconsider anticholinergic drugs as an option for asthma treatment. Tiotropium is the first anticholinergic drug that has been approved for children and adults with poorly controlled asthma and is currently considered as an option for steps 4 and 5 of the Global Initiative for Asthma. In large randomized clinical trials enrolling patients with moderate to severe asthma, add-on therapy with tiotropium has demonstrated to be efficacious in improving lung function, decreasing risk of exacerbation and slowing the worsening of disease; accordingly, tiotropium demonstrated to be non inferior compared to long acting beta-agonists in the maintenance treatment along with medium to high inhaled corticosteroids. In view of the numerous ancillary effects acting on inflammation, airway remodeling, mucus production and cough reflex, along with the good safety profile and the broad spectrum of efficacy demonstrated in different disease phenotypes, tiotropium can represent a beneficial alternative in the therapeutic management of poorly controlled asthma. The present extensive narrative review presents the pharmacological and pathophysiological basis that guided the rationale for the introduction of tiotropium in asthma treatment algorithm, with a particular focus on its conventional and unconventional effects; finally, data on tiotropium efficacy and safety. from recent randomized clinical trials performed in all age categories will be extensively discussed

Management of severe COPD exacerbations : focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide

The major determinant of the decline in lung function, quality of life, and the increased mortality risk in patients with COPD is represented by severe acute exacerbations of the disease, that is, those requiring patients' hospitalization, constituting a substantial social and health care burden in terms of morbidity and medical resource utilization. Different long-term therapeutic strategies have been proposed so far in order to prevent and/or reduce the clinical and social impact of these events, the majority of which were extrapolated from trials initially focused on the effect of long-acting muscarinic antagonist and subsequently on the efficacy of long-acting \u3b22-agonists in combination or not with inhaled corticosteroids. The option to employ all three classes of molecules combined, despite the limited amount of evidence in our possession, represents a choice currently proposed by international guidelines; however, current recommendations are often based mainly on observational studies or on the results of secondary outcomes in randomized controlled trials. The present narrative review evaluates the available trials that investigated the efficacy of inhaled therapy to prevent COPD exacerbations and especially severe ones, with a particular focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide fixed dose combination, which is the first treatment that comprises all the three drug classes, specifically tested for the prevention of moderate and severe COPD exacerbations

Investigation of Chaboche and Bouc–Wen Parameters of Quenched and Tempered Steel and Comparison of Model Predictive Capabilities

The aim of this paper is to model the elastic–plastic uniaxial behaviour of a quenched and tempered steel. The common Chaboche isotropic kinematic hardening model (CIKH) is introduced, and a physics-based procedure is proposed to determine its parameters. This procedure is based on strain- and stress-controlled tests and is focused on the stabilized cycles. The imposed cycle properties are the hysteresis area, the stress range, the slope at the inversion points, obtained from the stabilized cycles of strain-controlled tests, and the ratcheting rate extracted from a stress-controlled test. The novelty of the algorithm is to determine the hardening parameters from the global properties of the cycle rather than imposing a pointwise fitting, which is also implemented to calculate the parameters for a comparison. The Bouc–Wen model showed great flexibility in describing nonlinear behaviours, corresponding to different physical phenomena, through an appropriate tuning of its parameter values. In this paper, another optimization approach is developed to estimate the Bouc–Wen coefficients and accurately describe the same experimental cycles. The performances of the Bouc–Wen model are compared with the predictions of the Chaboche model, and a discussion comparing the techniques used to reproduce cyclic plastic behaviour is provided

Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease

Background. Chronic obstructive lung disease (COPD) is characterised by partially reversible usually progressive airflow limitation caused by inflammation and remodelling. Stromelysin-1 (MMP-3) has regulatory activity on other matrix-metalloproteinases. Altered MMP-3 activity has been described in different diseases. We investigated the role of a promoter MMP-3 polymorphism in determining susceptibility and severity of COPD. Methods. We studied 147 patients with COPD in stable conditions and distinguished two groups based on FEV1 values. In 100 patients functional modifications across a two-year period were noted. 133 healthy subjects were used as controls. Genotyping for the –1171 5A/6A MMP-3 polymorphism was performed using nucleotide sequencing. Results. No difference was noted in the genotype distribution between COPD patients and controls. However, among patients with severe disease 6A/6A genotype and 6A allelic frequency were significantly more represented than among mild-moderate patients (p < 0.05). The 6A/6A genotype was also associated with a higher FEV1 decline over time. Conclusions. Our data suggests that –1171 6A allele does not represent a risk factor for the development of COPD while it is associated with more severe disease and different functional decline. We hypothesise that a disregulation of MMP-3, possibly caused by the –1171 5A/6A polymorphism or other linked variants, may lead to different progression in COPD